Biological Risk in Taiwan, Indonesia, Mexico, England and U.S.

描述(由申请者提供)：该项目的目的是在具有不同流行病学、经济、行为和文化条件的一系列国家中检查特定年龄的生物标记物的变化和特定年龄的生理失调的发病情况。我们还将把人口、社会和行为因素与美国、英国、台湾、墨西哥和印度尼西亚等国家的风险发生联系起来。该项目使用的数据包括以下具有全国代表性的样本，这些样本已适当地进行了跨国比较：2006年和2010年的健康和退休研究(HRS)、2004年和2008年的英国老龄化纵向研究(ELSA)、2000年和2006年的社会环境和老龄化生物标记研究(SEBAS)、2002年、2006年和2009年的墨西哥家庭生活调查(MxFLS)以及2000年和2007-8年的印度尼西亚家庭生活调查(IFLS)。最近在世界许多地区收集的多波生物标志物数据提供了一个无与伦比的机会，在具有不同健康历史、健康行为和社会、文化和卫生系统特征的国家一级，系统和全面地研究特定年龄段的生理变化的开始，以及各种健康结果的风险流行率。 与公共卫生相关：在流行病学、经济、行为和文化状况各不相同的一系列国家中，重要的是了解生物标志物的特定年龄变化以及生理失调的流行率和特定年龄的发病情况。跨国比较的结果不仅将有助于更好地了解各国之间的健康差异，还将有助于理解不同情况下的生物衰老过程。此外，澄清人口、社会和行为因素与生物风险之间的不同联系将有助于更好地理解如何改善不同人群的生理状态。

DESCRIPTION (provided by applicant): The aim of this project is to examine age-specific changes in biomarkers and age-specific onset of physiological dysregulation across a range of countries with varying epidemiological, economic, behavioral and cultural conditions. We will also link demographic, social, and behavioral factors to the onset of risk across countries including the U.S., England, Taiwan, Mexico, and Indonesia. The data used in this project include the following nationally representative samples that have been harmonized as appropriate for cross-country comparisons: the Health and Retirement Study (HRS) for 2006 and 2010, the English Longitudinal Study of Ageing (ELSA) for 2004 and 2008, the Social Environment and Biomarkers of Aging Study (SEBAS) for 2000 and 2006, the Mexican Family Life Survey (MxFLS) for 2002, 2006, and 2009, and the Indonesia Family Life Survey (IFLS) for 2000 and 2007-8. Recent collection of multiple waves of biomarker data in many areas of the world provides an unparalleled opportunity to systematically and comprehensively study age-specific onset of physiological change, as well as prevalence of risk for a variety of health outcomes, at the national level in countries with varying health histories, health behaviors, and social, cultural and health system characteristics. PUBLIC HEALTH RELEVANCE: It is important to understand age-specific changes in biomarkers and prevalence and age-specific onset of physiological dysregulation across a range of countries with varying epidemiological, economic, behavioral and cultural conditions. Findings from cross-country comparisons will not only provide better understanding of health differences across countries, they will also contribute to understanding the process of biological aging in different circumstances. In addition, clarifying differential links between demographic, social, and behavioral factors with the biological risk will provide better understanding on how to improve physiological status in different populations.